Ginsenosides regulation of lysophosphatidylcholine profiles underlies the mechanism of Shengmai Yin in attenuating atherosclerosis

Exploring the Mechanism of Shengmai Yin for Coronary Heart Disease Based on Systematic Pharmacology and Chemoinformatics

(2020) Yan Jiang et al.   BIOSCIENCE REPORTS

Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE−/− Mice by Regulating PPARγ/FAK Signaling Pathway

(2020) Jianan Geng et al.   Frontiers in Pharmacology

Sheng-Mai Yin exerts anti-inflammatory effects on RAW 264.7 cells and zebrafish

(2020) Yuanru Zheng et al.   JOURNAL OF ETHNOPHARMACOLOGY

Group IIA Secretory Phospholipase A 2 , Vascular Inflammation, and Incident Cardiovascular Disease

(2019) Akintunde O. Akinkuolie et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The major effective components in Shengmai Formula interact with sodium taurocholate co-transporting polypeptide

(2019) Tao Zhan et al.   PHYTOMEDICINE

Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice

(2019) Senlin Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

Ginsenoside Rg3 Mitigates Atherosclerosis Progression in Diabetic apoE–/– Mice by Skewing Macrophages to the M2 Phenotype

(2018) Mengqi Guo et al.   Frontiers in Pharmacology

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype

(2017) Xue Zhang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Optimizing Cholesterol Treatment in Patients With Muscle Complaints

(2017) Robert S. Rosenson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice

(2017) Jing-Hui Sun et al.   Lipids in Health and Disease

Ginsenoside Rb1 Enhances Atherosclerotic Plaque Stability by Improving Autophagy and Lipid Metabolism in Macrophage Foam Cells

(2017) Lei Qiao et al.   Frontiers in Pharmacology

MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids

(2016) Linlin Shi et al.   CARBOHYDRATE POLYMERS

Oxidized LDL induced extracellular trap formation in human neutrophils via TLR-PKC-IRAK-MAPK and NADPH-oxidase activation

(2016) Deepika Awasthi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects

(2016) Tae Woong Cha et al.   HYPERTENSION RESEARCH

Comprehensive Plasma Metabolomic Analyses of Atherosclerotic Progression Reveal Alterations in Glycerophospholipid and Sphingolipid Metabolism in Apolipoprotein E-deficient Mice

(2016) Vi T. Dang et al.   Scientific Reports

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Anti-inflammatory therapies for atherosclerosis

(2015) Magnus Bäck et al.   Nature Reviews Cardiology

Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis

(2015) A. Warnatsch et al.   SCIENCE

Ginseng alleviates cyclophosphamide-induced hepatotoxicity via reversing disordered homeostasis of glutathione and bile acid

(2015) He Zhu et al.   Scientific Reports

Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation

(2014) Xiaofei Qin et al.   CELLULAR IMMUNOLOGY

Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis

(2013) Daniel Urban et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality

(2012) Lars Lind et al.   EUROPEAN HEART JOURNAL

Phospholipase A2 enzymes and the risk of atherosclerosis

(2012) R. S. Rosenson et al.   EUROPEAN HEART JOURNAL

Early Inflammatory Reactions in Atherosclerosis Are Induced by Proline-Rich Tyrosine Kinase/Reactive Oxygen Species–Mediated Release of Tumor Necrosis Factor-α and Subsequent Activation of the p21 Cip1 /Ets-1/p300 System

(2011) Asako Katsume et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice

(2010) Jie Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Lysophosphatidylcholine Activates a Novel PKD2-Mediated Signaling Pathway That Controls Monocyte Migration

(2009) Mingqi Tan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Metabolism and atherogenic disease association of lysophosphatidylcholine

(2009) Gerd Schmitz et al.   ATHEROSCLEROSIS

Effect of Shengmai Injection (生脉注射液) on cardiac function and inflammatory reaction in patients with acute coronary syndrome

(2008) Ya-chen Zhang et al.   Chinese Journal of Integrative Medicine